
    
      Consecutive patients undergoing transjugular liver biopsy will be randomly assigned to
      receive either placebo or midazolam (0.02 mg/kg) or 0.02 mg/kg midazolam combined with 1
      mg/kg pethidine before the procedure.
    
  